ADI 2016 | Investigating the reversal of cognitive decline in Alzheimer’s disease

Kate Swaffer

At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from 21–24 April 2016, Kate Swaffer, MSc (Dementia Care), BPsych, BA, Grad Dip Grief Counseling, RN, from Dementia Alliance International, discusses the early clinical development of a novel therapeutic approach for reversing cognitive decline in people with Alzheimer’s disease, led by Professor Dale Bredesen, from the Easton Center for Alzheimer’s Research at UCLA and the Buck Institute for Research on Aging, Novato, CA.

Share this video  
Similar topics